Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas

被引:14
作者
Ohgami, Robert S. [1 ]
Zhao, Shuchun [1 ]
Natkunam, Yasodha [1 ]
机构
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
关键词
T-cell histiocyte rich large B-cell lymphoma; PD-1+T cells; Large B-cell lymphoma; PREDOMINANT HODGKIN LYMPHOMA; PD-L1; EXPRESSION; PATTERNS; IMMUNOGLOBULIN; LOCALIZATION; SURVIVAL;
D O I
10.1309/AJCPFJWKQ6GTVQE6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To characterize the clinicopathologic features of cases of large B-cell lymphomas, poor in B cells and densely rich in programmed cell death-1 (PD-1)+ reactive T cells, which can mimic T-cell lymphomas. Methods: A single-institute retrospective review of cases between 2010 and 2013 was performed. Results: Of 178 cases of large B-cell lymphomas, eight cases of large B-cell lymphomas poor in B cells and diffusely rich in sheets of PD-1+ T cells were identified. These cases either were initially misdiagnosed as a T-cell lymphoma or substantiated a broader differential diagnosis including a T-cell lymphoma. Five cases were T-cell histiocyte rich large B-cell lymphomas, and three cases were diagnosed as large B-cell lymphomas rich in T cells. In three of these cases, a subset of the PD-1+ T cells showed either morphologic nuclear atypia or atypical expression of T-cell antigens on flow cytometry and/or immunohistochemistry. Conclusions: Large B-cell lymphomas poor in B cells and rich in T cells can have diffuse sheets of reactive PD-1+ T cells, some with atypical morphologic and immunophenotypic features mimicking a T-cell lymphoma. Careful assessment of the immunoarchitecture and background inflammatory and stromal cells can prevent erroneous diagnoses in such cases.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 23 条
  • [1] PD-L1 Expression in B-cell Lymphomas and Virus-Associated Malignancies-Letter
    Andersen, Mads Hald
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (14) : 4017 - 4017
  • [2] Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
    Andorsky, David J.
    Yamada, Reiko E.
    Said, Jonathan
    Pinkus, Geraldine S.
    Betting, David J.
    Timmerman, John M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4232 - 4244
  • [3] Batra R, 2012, APPL IMMUNOHISTO M M, V20, P325, DOI 10.1097/PAI.0b013e318233d72a
  • [4] Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
    Brueggemann, M.
    White, H.
    Gaulard, P.
    Garcia-Sanz, R.
    Gameiro, P.
    Oeschger, S.
    Jasani, B.
    Ott, M.
    Delsol, G.
    Orfao, A.
    Tiemann, M.
    Herbst, H.
    Langerak, A. W.
    Spaargaren, M.
    Moreau, E.
    Groenen, P. J. T. A.
    Sambade, C.
    Foroni, L.
    Carter, G. I.
    Hummel, M.
    Bastard, C.
    Davi, F.
    Delfau-Larue, M. -H.
    Kneba, M.
    van Dongen, J. J. M.
    Beldjord, K.
    Molina, T. J.
    [J]. LEUKEMIA, 2007, 21 (02) : 215 - 221
  • [5] High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma
    Carreras, Joaquim
    Lopez-Guillermo, Armando
    Roncador, Giovanna
    Villamor, Neus
    Colomo, Lluis
    Martinez, Antonio
    Hamoudi, Rifat
    Howat, William J.
    Montserrat, Emili
    Campo, Elias
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1470 - 1476
  • [6] PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
    Chen, Benjamin J.
    Chapuy, Bjoern
    Jing Ouyang
    Sun, Heather H.
    Roemer, Margaretha G. M.
    Xu, Mina L.
    Yu, Hongbo
    Fletcher, Christopher D. M.
    Freeman, Gordon J.
    Shipp, Margaret A.
    Rodig, Scott J.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3462 - 3473
  • [7] Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
    Churchill, Hywyn R. O.
    Roncador, Giovanna
    Warnke, Roger A.
    Natkunam, Yasodha
    [J]. HUMAN PATHOLOGY, 2010, 41 (12) : 1726 - 1734
  • [8] Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
    Dorfman, DM
    Brown, JA
    Shahsafaei, A
    Freeman, GJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) : 802 - 810
  • [9] T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large-B-cell lymphomas
    Felgar, RE
    Steward, KR
    Cousar, JB
    Macon, WR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (06) : 1707 - 1715
  • [10] PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
    Good-Jacobson, Kim L.
    Szumilas, Courtney G.
    Chen, Lieping
    Sharpe, Arlene H.
    Tomayko, Mary M.
    Shlomchik, Mark J.
    [J]. NATURE IMMUNOLOGY, 2010, 11 (06) : 535 - U107